Browsing by Keyword : Safety

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 29 of 29

Pub YearTitleAJOU Author(s)
2022Adverse Events and Safety of Oral Cyclosporine for Dermatoses among Children and Adolescents: A Single Center Study강희영, 박영준, 최지웅
2015Application and Developmental Strategies for Community-Based Injury Prevention Programs of the International Safe Communities Movement in Korea.조준필
2014Clinical Usefulness of Fentanyl Matrix Patch for the Patients with Chronic Low Back Pain전창훈, 정남수
2023Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis김현아
2024Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study박래웅, 손상준
2024Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach현학준
2018Complications following ultrasound-guided core needle biopsy of thyroid nodules: a systematic review and meta-analysis하은주
1997Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase.김선용, 서정호
2008Double-blind, Randomized, Multi-center, Comparative Clinical Trial of Sibutramine Mesilate with Sibutramine Hydrochloride for Evaluating Efficacy and Safety in Obese Patients김범택, 이관우
2005Effect of Community Based Child Safety Education Program for Child Care Teachers방경숙
2018Effect of Growth Hormone Therapy on Height Velocity in Korean Children with Idiopathic Short Stature: A Phase III Randomised Controlled Trial황진순
2005Effect of Safety Education for Mothers with Infants방경숙
1999Efficacy and Safety of Glimepiride: A Novel Sulfonylurea Drug Compared with Gliclazide in the Treatment of Type 2 Diabetes Mellitus: an Open, Randomized Comparative Multi-Center Clinical Study이관우
2020Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies서창희
2023Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial김은진, 허중연
2014Implementation and Results of a Survey on Safe Community Programs in Gangbuk-gu, Korea: Focusing on Participants at a Local Public Health Center조준필
2014Oral immunotherapy for the treatment of immediate type food allergy이수영
2021Rapid symptom improvement in major depressive disorder using accelerated repetitive transcranial magnetic stimulation노재성, 손상준
2012Roles of a hospital for community safety promotion이정아, 조준필
2019Safety and Effectiveness Analysis of Kivexa(R) (lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean Patients최영화
2023Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data서창희
2022Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial손성연
2014Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation.오창권
2023Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial박광주
2013Safety and Reactogenicity of the Inactivated Poliomyelitis Vaccine (PoliorixTM) in Korea (2006-2012)박문성
2018Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trial김광민
2024Safety outcomes of antipsychotics classes in drug-naïve patients with first-episode schizophrenia: A nationwide cohort study in South Korea박래웅
2023The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination최영화
2023Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial최진혁
1

Browse